STAT
Eric Boodman writes for STAT that MIT researchers have developed a technique to produce biopharmaceuticals in remote locations. “Instead of making the drugs and then trying to keep them refrigerated...
View ArticleThe Atlantic
MIT researchers have developed a new technique for making vaccines using freeze-dried cells, reports Ed Yong for The Atlantic. Yong explains that in addition to producing medicines, the technique...
View ArticleBoston Globe
Henri Termeer, a life member of the MIT Corporation who was known as one of the founding fathers of the biotech industry, died at age 71, write Robert Weisman and Bryan Marquard for The Boston Globe....
View ArticleXconomy
Xconomy reporter Ben Fidler writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation who died at age 71. Institute Prof. Phillip Sharp explains that Termeer was, “a...
View ArticleThe Wall Street Journal
Wall Street Journal reporter James Hagerty writes about the life and legacy of Henri Termeer, a life member of the MIT Corporation known for his work as a pioneering leader in the field of biotechnology.
View ArticleNew Scientist
New Scientist reporter Andy Coghlan writes that MIT researchers have engineered bacteria to produce full-color, living photocopies. Coghlan explains that the technique could “enable finer control of...
View ArticleBoston Globe
During a panel discussion during the Koch Institute’s 16th Annual Cancer Research Symposium, participants discussed how the convergence of biology and engineering could accelerate treatments for cancer...
View ArticleBoston Magazine
Boston Magazine reporter Rowan Walrath writes that MIT researchers have developed a new technique that could be used to deliver multi-drug vaccines. The researchers developed a new method for...
View ArticleNew Scientist
MIT researchers have developed a new way of creating drug-carrying particles that could allow multiple doses of a vaccine to be delivered over an extended period of time, reports Matt Reynolds for New...
View ArticleGuardian
Guardian reporter Nicola Davis writes that MIT researchers have developed a new approach that could be used to deliver multiple vaccines in one injection. Davis explains that the technique could prove...
View ArticleBBC News
BBC News reporter James Gallagher writes that MIT researchers have developed a new technology that could eventually enable doctors to administer multiple vaccines in one shot.
View ArticleUnited Press International (UPI)
UPI reporter Alan Mozes writes that MIT researchers have developed a new capsule that could be used to deliver a week’s worth of HIV medications in a single dose. “The new pill sits in the stomach for...
View ArticleBBC News
MIT researchers have developed a new slow-release capsule that could free HIV patients from having to take a daily dose of medication, according to the BBC. “Changing a medication so it only needs to...
View ArticleHuffPost
HuffPost reporter Sophie Gallagher writes that MIT researchers have developed a new capsule that would allow patients to take a week’s worth of HIV medications in one dose. The researchers believe...
View ArticleGizmodo
MIT researchers have developed a new capsule that allows HIV medication to be delivered over the course of a week, and could allow patients to forgo daily pills, reports Ed Cara for Gizmodo....
View ArticleNew Scientist
Prof. Linda Griffith has developed ten miniature models of human organs “to create the closest we’ve come yet to a human-on-a-chip,” writes Jessica Hamzelou for New Scientist. “This is still only a...
View ArticleTechCrunch
Prof. Linda Griffith has created a “complex platform where researchers can put up to 10 organ tissues in separate compartments, regulating the flow of substances and medications between them in real...
View ArticleUnited Press International (UPI)
Researchers have developed a microfluidic platform called “physiome on a chip”, which allows them to determine how certain drugs will affect up to 10 different organs. “Because the animal and human...
View ArticleBoston Globe
Elise Takahama writes for The Boston Globe that MIT researchers have developed a new technique to create “xenoproteins,” manmade proteins that could be used to battle infectious diseases like Ebola....
View ArticleWBUR
Prof. Andrew Lo speaks with Lisa Mullins of WBUR’s All Things Considered about investing in biotech. Lo explains that, “if we can use finance to reduce the risk, we will actually be able to bring lots...
View Article
